Want to be on the cutting edge of disease treatment? Learn how companies like Immunyx Pharma are on the front lines in the battle against unknown diseases with the JLABS/BARDA Blue Knight program. Seth Salpeter, Co-Founder and CEO of Immunyx Pharma guests on BioTalk with Rich Bendis
Dr. Gary Disbrow, Biomedical Advanced Research and Development Authority (BARDA) (EP.113)
Brian Castleberry, of the Maryland Department of Commerce & Robin Wiener of Get Real Health (EP.112)
Doug Falk, Vita Therapeutics (EP.111)
Dave Saunders, Galen Robotics (EP.110)
Mike Gill, Maryland Commerce Secretary (EP.109)
Ray Blanchard, Qiagen (EP.108)
Darryll J. Pines, University of Maryland (EP.107)
Ken Malone, Early Charm Ventures (EP.106)
Ron Kurz, Canon Virginia, Inc. (EP.105)
Marty Rosendale, Maryland Tech Council (EP.104)
Ron Piervincenzi, Ph.D., United States Pharmacopeia (EP.103)
Geoffrey Lynn, Vaccitech (EP.101)
Bill Enright, Vaccitech (EP.101)
Ellington West, Sonavi Labs (EP.100)
Amritha Jaishankar, PhD, Maryland Stem Cell Research Fund (MSCRF) (EP.99)
Mr. Hakdo Kim, President, Korea SMEs & Startups Agency KOSME)
Seth Toback, Novavax and Divya Chadha Manek, National Institute for Health Research (NIHR) (EP.97)
From the 7th Annual BioHealth Capital Region Forum - Dr. Tara Schwetz, Assistant Director for Biomedical Science Initiatives, White House Office of Science and Technology Policy (OSTP) (EP.96)
From the 7th Annual BioHealth Capital Region Forum - Dr. Anthony Fauci (EP.95)
Dr. Xavier Barril, Gain Therapeutics, and Hartaj Singh, Oppenheimer & Co. Inc. (EP.94)
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money